N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide

C25H26FN7O — CID 160798399

IUPACN-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide
SMILESCc1ccc(C2(C(=O)Nc3ccc(-n4cnc(C(C)(C)C)c4)c(-c4nn[nH]n4)c3)CC2)c(F)c1
InChIInChI=1S/C25H26FN7O/c1-15-5-7-18(19(26)11-15)25(9-10-25)23(34)28-16-6-8-20(17(12-16)22-29-31-32-30-22)33-13-21(27-14-33)24(2,3)4/h5-8,11-14H,9-10H2,1-4H3,(H,28,34)(H,29,30,31,32)
InChIKeySCSWNSVVVLTSTQ-UHFFFAOYSA-N
MW459.53 g/mol
LogP4.47
Rot. Bonds5

About N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide

N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide (PubChem CID 160798399) has the molecular formula C25H26FN7O and a molecular weight of 459.53 g/mol. Its IUPAC name is N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide.

Molecular Properties

Compound NameN-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide
PubChem CID160798399
Molecular FormulaC25H26FN7O
Molecular Weight459.53 g/mol
Exact Mass459.22
IUPAC NameN-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide
SMILESCc1ccc(C2(C(=O)Nc3ccc(-n4cnc(C(C)(C)C)c4)c(-c4nn[nH]n4)c3)CC2)c(F)c1
InChIInChI=1S/C25H26FN7O/c1-15-5-7-18(19(26)11-15)25(9-10-25)23(34)28-16-6-8-20(17(12-16)22-29-31-32-30-22)33-13-21(27-14-33)24(2,3)4/h5-8,11-14H,9-10H2,1-4H3,(H,28,34)(H,29,30,31,32)
InChIKeySCSWNSVVVLTSTQ-UHFFFAOYSA-N
XLogP4.47
TPSA101.38 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500459.53
LogP ≤ 54.47
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide?
The IUPAC name of N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide (CID 160798399) is N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide.
What is the SMILES notation for N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide?
The canonical SMILES for N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide is Cc1ccc(C2(C(=O)Nc3ccc(-n4cnc(C(C)(C)C)c4)c(-c4nn[nH]n4)c3)CC2)c(F)c1.
What is the InChIKey of N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide?
The InChIKey is SCSWNSVVVLTSTQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26FN7O/c1-15-5-7-18(19(26)11-15)25(9-10-25)23(34)28-16-6-8-20(17(12-16)22-29-31-32-30-22)33-13-21(27-14-33)24(2,3)4/h5-8,11-14H,9-10H2,1-4H3,(H,28,34)(H,29,30,31,32).
What are the key properties of N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide?
N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide has a molecular weight of 459.53 g/mol, XLogP of 4.47, 5 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(4-tert-butylimidazol-1-yl)-3-(2H-tetrazol-5-yl)phenyl]-1-(2-fluoro-4-methylphenyl)cyclopropane-1-carboxamide is sourced from PubChem (CID 160798399), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).